CD8A and COVID-19: In another study involving flow cytometry-based PBMCs analysis from moderately to severely ill COVID-19 patients, around 1.4% and 1.3% virus-specific CD4+ and CD8+ T cells, respectively, were detected in all patients post 15 days ICU admission.